Literature DB >> 10677754

Parasitological cure of Chagas disease: is it possible? Is it relevant?

J A Urbina1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10677754     DOI： 10.1590/s0074-02761999000700068

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  13 in total

1.  Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.

Authors:  Victor B Saraiva; Daniel Gibaldi; José O Previato; Lucia Mendonça-Previato; Marcelo T Bozza; Célio G Freire-De-Lima; Norton Heise
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.

Authors:  Valeria S Rosso; Sergio H Szajnman; Leena Malayil; Melina Galizzi; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem       Date:  2011-04-01       Impact factor: 3.641

4.  Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.

Authors:  Ana Maria de Castro; Alejandro Ostermayer Luquetti; Anis Rassi; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2006-03-29       Impact factor: 2.289

5.  In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; R Lira; G Visbal; J Bartrolí
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 6.  Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?

Authors:  Galina I Lepesheva
Journal:  Expert Opin Drug Discov       Date:  2013-09-30       Impact factor: 6.098

7.  Antitrypanosomal activity of Senna villosa in infected BALB/c mice with Trypanosoma cruzi during the sub acute phase of infection.

Authors:  Matilde Jimenez-Coello; Eugenia Guzman-Marin; Salud Perez-Gutierrez; Glendy Marilu Polanco-Hernandez; Karla Yolanda Acosta-Viana
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

8.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.

Authors:  Pablo D Elicio; María N Chao; Melina Galizzi; Catherine Li; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  Eur J Med Chem       Date:  2013-09-18       Impact factor: 6.514

10.  Dibenzylideneacetones Are Potent Trypanocidal Compounds That Affect the Trypanosoma cruzi Redox System.

Authors:  Danielle Lazarin-Bidóia; Vânia Cristina Desoti; Solange Cardoso Martins; Fabianne Martins Ribeiro; Zia Ud Din; Edson Rodrigues-Filho; Tânia Ueda-Nakamura; Celso Vataru Nakamura; Sueli de Oliveira Silva
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.